Mark Reiboldt is a Senior Vice President and Director of Strategy at Coker Group, where he specializes in financial advisory and transaction services for hospitals, health systems and other healthcare organizations. These transactions include mergers and acquisitions, divestitures, equity purchases, physician alignment deals and joint ventures. His advisory services often entail acquisition/investment due diligence, valuation services, transaction management, buyside representation, strategic alternatives processes and post-merger integration.
Mr. Reiboldt regularly presents at numerous national and regional conferences on a variety of topics, such as healthcare financial transactions, valuation trends, capital markets issues and healthcare public policy. He has also contributed as an author on articles and books for a variety of publications covering a wide range of topics related to his area of focus, and his pieces have been featured in numerous industry and mainstream media publications.
Prior to joining Coker in 2005, Mr. Reiboldt was an analyst in the Transaction Services Group at Trammell Crow Company, where he worked on multi-billiondollar merger transactions for Fortune 100 companies in a range of industries and sectors. And prior to entering the private sector, Mark began his career working with various public policy organizations based in Washington, DC.
Mr. Reiboldt received an MSc in financial economics from the University of London and a BA in political science from Georgia State University. He also successfully completed the High Potentials Leadership executive management program at Harvard Business School. Mark is a member of the board of directors of the Coker Foundation, which oversees healthcare and aid relief initiatives in the U.S. and abroad.